A detailed history of Manchester Capital Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Manchester Capital Management LLC holds 70 shares of INCY stock, worth $4,243. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70
Previous 62 12.9%
Holding current value
$4,243
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$56.55 - $66.59 $452 - $532
8 Added 12.9%
70 $3,000
Q4 2023

Feb 08, 2024

BUY
$52.16 - $64.19 $2,973 - $3,658
57 Added 1140.0%
62 $3,000
Q3 2023

Nov 09, 2023

BUY
$57.77 - $65.93 $288 - $329
5 New
5 $0
Q1 2021

May 13, 2021

SELL
$76.02 - $100.5 $1,824 - $2,412
-24 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$80.74 - $97.7 $1,211 - $1,465
15 Added 166.67%
24 $2,000
Q3 2020

Oct 27, 2020

BUY
$85.07 - $109.69 $765 - $987
9 New
9 $1,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Manchester Capital Management LLC Portfolio

Follow Manchester Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.